Table 1.
Demographic and electroclinical variables of selected patients
| Electroclinical details | IEDs during functional MRI | ||||||
|---|---|---|---|---|---|---|---|
| Patient ID | Age | Sex | ILAE syndrome | IEDs type | AEDs | IEDs, n | Mean length (s) |
| GGE PS+ | |||||||
| 1 | 17 | M | EMA | GSW | VPA | 0 | 0 |
| 2 | 29 | F | EMA | GSW | LEV; VPA | 1 | 3.43 |
| 3 | 56 | F | EMA | GSW | VPA | 0 | 0 |
| 4 | 35 | F | EMA | GSW | LTG; CLB | 0 | 0 |
| 5 | 30 | F | EMA | GSW | VPA | 0 | 0 |
| 6 | 26 | F | EMA | GSW | LEV; VPA | 2 | 3.72 |
| 7 | 20 | F | EMA | GSW | VPA, LTG | 0 | 0 |
| 8 | 21 | F | EMA | GSW | LEV | 0 | 0 |
| 9 | 20 | M | EMA | GSW | VPA | 2 | 3.78 |
| 10 | 17 | M | EMA | GSW | PB; ZNS; ETS | 0 | 0 |
| 11 | 17 | F | EMA | GSW | LEV | 1 | 2.05 |
| 12 | 20 | F | EMA | GSW | ETS; VPA | 2 | 2.23 |
| 13 | 35 | F | JME | GSW | VPA | 2 | 1.45 |
| 14 | 19 | F | JME | GSW | LEV | 0 | 0 |
| 15 | 28 | M | JME | GSW | PB; TPM | 0 | 0 |
| 16 | 18 | M | JME | GSW | LEV | 2 | 2.57 |
| GGE PS− | |||||||
| 1 | 33 | F | JAE | GSW | – | 2 | 3.17 |
| 2 | 17 | F | JAE | GSW | LEV | 0 | 0 |
| 3 | 53 | M | JAE | GSW | LEV; VPA | 0 | 0 |
| 4 | 20 | M | JAE | GSW | VPA | 3 | 0.91 |
| 5 | 21 | F | JAE | GSW | VPA | 0 | 0 |
| 6 | 24 | F | JAE | GSW | LEV; CLB | 0 | 0 |
| 7 | 18 | F | JAE | GSW | VPA | 0 | 0 |
| 8 | 17 | M | JAE | GSW | VPA | 0 | 0 |
| 9 | 18 | F | JAE | GSW | VPA | 0 | 0 |
| 10 | 28 | M | JAE | GSW | VPA; LEV | 1 | 3.99 |
| 11 | 41 | F | GGE with TC | GSW | PB | 1 | 1.46 |
| 12 | 16 | F | JAE | GSW | LEV | 0 | 0 |
| 13 | 24 | F | GGE with TC | GSW | VPA; TPM | 0 | 0 |
| Focal epilepsy | |||||||
| 1 | 19 | F | FE | R Fr-T S | LEV; OXC | 0 | 0 |
| 2 | 30 | F | FE | R P SW | CBZ | 0 | 0 |
| 3 | 30 | F | FE | L T S | LTG; CBZ; LEV | 0 | 0 |
| 4 | 50 | F | FE | L T SW | OXC; LEV | 7 | <1 |
| 5 | 23 | F | FE | R T S | LCM; VPA | 0 | 0 |
| 6 | 33 | F | FE | R Fr-T SW | CBZ; VPA | 0 | 0 |
| 7 | 17 | F | FE | L C-T SW | – | 5 | <1 |
| 8 | 16 | F | FE | L Fr-T ShW | LEV; PB; CBZ | 0 | 0 |
| 9 | 23 | M | FE | R Fr SW | VPA | 6 | <1 |
| 10 | 18 | M | FE | R T SW | CBZ; VPA | 0 | 0 |
| 11 | 19 | F | FE | L Fr-T S | OXC | 0 | 0 |
| 12 | 19 | M | FE | B C-T S | – | L 4; R 5 | <1 |
| 13 | 32 | M | FE | LT S | LEV; TGB; LCM | 0 | 0 |
| 14 | 35 | F | FE | R T SW | OXC | 0 | 0 |
| 15 | 22 | M | FE | L T SW | OXC; LEV | 0 | 0 |
AEDs = antiepileptic drugs; B = bilateral; C = central; CBZ = carbamazepine; CLB = clobazam; ETS = etosuccimide; F = female; Fr = frontal; FE = focal epilepsy; GGE with TC = genetic generalized epilepsies with tonic-clonic seizures only; GSW = generalized spike and wave; IEDs = interictal epileptic discharges; JAE = juvenile absence epilepsy; JME = juvenile myoclonic epilepsy; L = left; LCM = lacosamide; LEV = levetiracetam; LTG = lamotrigine; M = male; O = occipital; OXC = oxcarbamazepine; P = parietal; PB = phenobarbital; R = right; S = spike; ShW = sharp wave; SW = spike and wave; T = temporal; TGB = tiagabine; TPM = topiramate; VPA = valproate; ZNS = zonisamide.